Clinical Trials Logo

Clinical Trial Summary

To determine the ability of a monophasic oral contraceptives ("OC") regimen of Levonorgestrel ("LNG") 90 mg and Ethinyl Estradiol ("EE") 20 mg to inhibit ovulation during 84 days of continuous therapy.


Clinical Trial Description

n/a


Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00254189
Study type Interventional
Source Wyeth is now a wholly owned subsidiary of Pfizer
Contact
Status Completed
Phase Phase 2
Start date December 2002
Completion date October 2004

See also
  Status Clinical Trial Phase
Completed NCT01129245 - The Effect of a Non-hormonal Cox-2 Inhibitor (Celebrex) on Ovulation N/A
Completed NCT03778099 - The Effect of Cinnamon on Ovulation Induction in Women With Polycystic Ovary Syndrome Phase 3
Completed NCT00796133 - A Phase 2, Dose-finding, Cross-over Study to Evaluate the Effect of a NES/E2 Transdermal Gel Delivery on Ovulation Suppression in Normal Ovulating Women Phase 2
Recruiting NCT04196595 - Apple Women's Health Study
Completed NCT05448378 - Evaluation of D-chiro-inositol Treatments N/A
Recruiting NCT06142097 - Sensor Technology Assessments of Reproductive Target Study
Completed NCT04382001 - Heart Rate Variability During the Menstrual Cycle
Recruiting NCT05999123 - Menstrual Cycle Study
Completed NCT04008277 - Investigation of Heart Rate Variability During the Menstrual Cycle
Recruiting NCT02571543 - Can Ibuprofen Delay Ovulation in Natural Cycle-IVF? Phase 2
Completed NCT01802060 - Accuracy of SPD Persona LH Assay When Compared to Ultrasound Observed Ovulation and Other Indices of Ovulation N/A
Suspended NCT03106454 - Ovulation Incidence in Oral Contraceptive Users Phase 3